| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30019337 |
| PharmacoGx | BRD-K30019337 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WFDC13 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | FNDC3A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | CCDC171 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | CDK5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | DDX25 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | GDI1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | RDM1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | METAP1D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | MCF2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | ABHD14B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
